SMS Pharmaceuticals Q1 Results
- BSE: 532815
- NSE: SMSPHARMA
- ISIN: INE812G01025
- Sector: Biotechnology & Drugs
BSE
318.45
-0.45 (-0.14%)
-0.45 (-0.14%)Volume1.81 K
Updated: Wed 11 Feb, 2026 | 15:27:11
NSE
318.95
0.45 (0.14%)
0.45 (0.14%)Volume99.36 K
Updated: Wed 11 Feb, 2026 | 15:31:10
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - SMS Pharmaceuticals Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 166.43 | 216.03 | -22.96% | 139.32 | 19.46% |
| Depreciation/ Amortization | 9.75 | 8.64 | 12.88% | 8.38 | 16.36% |
| Operating Income | 29.62 | 32.17 | -7.93% | 25.13 | 17.85% |
| Net Income | 20.49 | 20.32 | 0.86% | 16.48 | 24.34% |
| Other Operating Expenses Total | 7.79 | 7.44 | 4.77% | 7.90 | -1.31% |
| Net Income Before Taxes | 24.37 | 28.52 | -14.57% | 21.83 | 11.63% |
| Total Revenue | 196.05 | 248.20 | -21.01% | 164.45 | 19.21% |
| Selling/ General/ Admin Expenses Total | 18.18 | 26.63 | -31.71% | 16.88 | 7.71% |
| Diluted Normalized EPS | 2.31 | 2.39 | -3.27% | 1.95 | 18.46% |